Merck & Co., Inc. (MRK) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	66.4B	64.9B	64.2B	60.1B	59.3B
Cost of Revenue	16.4B	18.2B	15.2B	16.1B	17.4B
Gross Profit	50.0B	46.7B	49.0B	44.0B	41.9B
Operating Expenses
R&D Expense	28.4B	12.5B	17.9B	30.5B	13.5B
SG&A Expense	10.4B	10.7B	10.1B	9.9B	9.7B
General & Admin Expense	2.9B	—	7.7B	7.6B	7.5B
Selling & Marketing Expense	—	—	2.4B	2.3B	2.2B
Other Expenses	250.0M	—	716.0M	620.0M	373.0M
Total Operating Expenses	39.0B	23.2B	28.8B	41.0B	23.6B
Cost and Expenses	55.3B	41.4B	43.9B	57.2B	41.0B
Operating Income (EBIT)	11.1B	23.5B	20.2B	3.0B	18.3B
Non-Operating
Interest Income	200.0M	343.0M	415.0M	365.0M	157.0M
Interest Expense	1.3B	1.4B	1.3B	1.1B	962.0M
Net Interest Income	(1.1B)	(1.0B)	(856.0M)	(781.0M)	(805.0M)
Other Non-Op Income/Expense	(5.1B)	(2.4B)	(285.0M)	(1.1B)	(1.8B)
Non-Operating Income (excl Interest)	3.8B	1.1B	(986.0M)	(81.0M)	876.0M
EBT (Pre-Tax Income)	5.9B	21.1B	19.9B	1.9B	16.4B
Income Tax Expense	2.8B	2.8B	2.8B	1.5B	1.9B
Bottom Line
Net Income	3.2B	18.3B	17.1B	365.0M	14.5B
Earnings from Cont. Ops	3.2B	18.3B	17.1B	377.0M	14.5B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	3.2B	18.3B	17.1B	365.0M	14.5B
Per Share
Basic EPS	$1.26	$7.30	$6.76	$0.14	$5.73
Diluted EPS	$1.25	$7.28	$6.74	$0.14	$5.71
Revenue Per Share	$26.86	$25.95	$25.34	$23.60	$23.41
Shares
Basic Shares Outstanding	2.5B	2.5B	2.5B	2.5B	2.5B
Diluted Shares Outstanding	2.5B	2.5B	2.5B	2.5B	2.5B
Profitability Metrics
EBITDA	13.8B	28.3B	25.7B	6.9B	21.3B
D&A	6.6B	5.8B	4.5B	3.9B	3.9B
EBIT	7.2B	22.4B	21.2B	3.0B	17.4B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026